Performance of urine cotinine and hypomethylation of AHRR and F2RL3 as biomarkers for smoking exposure in a population-based cohort.

There is a growing body of evidence demonstrating an association between smoking and DNA methylation. Accordingly, DNA methylation is now considered a promising biomarker of smoking exposure. We evaluated the relationship between methylation markers (AHRR and F2RL3) and urine cotinine as well as sel...

Full description

Bibliographic Details
Main Authors: Do-Hoon Lee, Sang-Hyun Hwang, Min Kyung Lim, Jin-Kyoung Oh, Da Young Song, E Hwa Yun, Eun Young Park
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5409156?pdf=render
_version_ 1819145938031083520
author Do-Hoon Lee
Sang-Hyun Hwang
Min Kyung Lim
Jin-Kyoung Oh
Da Young Song
E Hwa Yun
Eun Young Park
author_facet Do-Hoon Lee
Sang-Hyun Hwang
Min Kyung Lim
Jin-Kyoung Oh
Da Young Song
E Hwa Yun
Eun Young Park
author_sort Do-Hoon Lee
collection DOAJ
description There is a growing body of evidence demonstrating an association between smoking and DNA methylation. Accordingly, DNA methylation is now considered a promising biomarker of smoking exposure. We evaluated the relationship between methylation markers (AHRR and F2RL3) and urine cotinine as well as self-reported smoking status. DNA methylation levels of AHRR and F2RL3 in blood as well as urine cotinine were measured in 330 adults (46 to 87 years of age). Pyrosequencing was performed to measure DNA methylation of AHRR and F2RL3 associated with smoking exposure. The lung cancer risk associated with DNA methylation and urine cotinine was analyzed using logistic regression analysis. The AHRR and F2RL3 genes were significantly hypomethylated in current smokers compared to in individuals who have never smoked. An inverse relationship was observed between urine cotinine and methylation levels. Methylation of AHRR and F2RL3 distinguished current smokers from never-smokers with high accuracy. Logistic multivariate analysis showed that AHRR methylation is significantly associated with the risk of lung cancer (OR = 0.96, P = 0.011). Our study validated the smoking-associated DNA methylation markers reported in a Korean population-based cohort. In conclusion, DNA methylation of AHRR and F2RL3 provided accurate measures for smoking exposure. Methylation markers reflecting the long-term effect of smoking on the risk of lung cancer showed better performance in distinguishing former smokers from never-smokers.
first_indexed 2024-12-22T13:05:58Z
format Article
id doaj.art-8ba36f4ba02f45bd8871a6f94c043ea4
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-22T13:05:58Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-8ba36f4ba02f45bd8871a6f94c043ea42022-12-21T18:24:52ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01124e017678310.1371/journal.pone.0176783Performance of urine cotinine and hypomethylation of AHRR and F2RL3 as biomarkers for smoking exposure in a population-based cohort.Do-Hoon LeeSang-Hyun HwangMin Kyung LimJin-Kyoung OhDa Young SongE Hwa YunEun Young ParkThere is a growing body of evidence demonstrating an association between smoking and DNA methylation. Accordingly, DNA methylation is now considered a promising biomarker of smoking exposure. We evaluated the relationship between methylation markers (AHRR and F2RL3) and urine cotinine as well as self-reported smoking status. DNA methylation levels of AHRR and F2RL3 in blood as well as urine cotinine were measured in 330 adults (46 to 87 years of age). Pyrosequencing was performed to measure DNA methylation of AHRR and F2RL3 associated with smoking exposure. The lung cancer risk associated with DNA methylation and urine cotinine was analyzed using logistic regression analysis. The AHRR and F2RL3 genes were significantly hypomethylated in current smokers compared to in individuals who have never smoked. An inverse relationship was observed between urine cotinine and methylation levels. Methylation of AHRR and F2RL3 distinguished current smokers from never-smokers with high accuracy. Logistic multivariate analysis showed that AHRR methylation is significantly associated with the risk of lung cancer (OR = 0.96, P = 0.011). Our study validated the smoking-associated DNA methylation markers reported in a Korean population-based cohort. In conclusion, DNA methylation of AHRR and F2RL3 provided accurate measures for smoking exposure. Methylation markers reflecting the long-term effect of smoking on the risk of lung cancer showed better performance in distinguishing former smokers from never-smokers.http://europepmc.org/articles/PMC5409156?pdf=render
spellingShingle Do-Hoon Lee
Sang-Hyun Hwang
Min Kyung Lim
Jin-Kyoung Oh
Da Young Song
E Hwa Yun
Eun Young Park
Performance of urine cotinine and hypomethylation of AHRR and F2RL3 as biomarkers for smoking exposure in a population-based cohort.
PLoS ONE
title Performance of urine cotinine and hypomethylation of AHRR and F2RL3 as biomarkers for smoking exposure in a population-based cohort.
title_full Performance of urine cotinine and hypomethylation of AHRR and F2RL3 as biomarkers for smoking exposure in a population-based cohort.
title_fullStr Performance of urine cotinine and hypomethylation of AHRR and F2RL3 as biomarkers for smoking exposure in a population-based cohort.
title_full_unstemmed Performance of urine cotinine and hypomethylation of AHRR and F2RL3 as biomarkers for smoking exposure in a population-based cohort.
title_short Performance of urine cotinine and hypomethylation of AHRR and F2RL3 as biomarkers for smoking exposure in a population-based cohort.
title_sort performance of urine cotinine and hypomethylation of ahrr and f2rl3 as biomarkers for smoking exposure in a population based cohort
url http://europepmc.org/articles/PMC5409156?pdf=render
work_keys_str_mv AT dohoonlee performanceofurinecotinineandhypomethylationofahrrandf2rl3asbiomarkersforsmokingexposureinapopulationbasedcohort
AT sanghyunhwang performanceofurinecotinineandhypomethylationofahrrandf2rl3asbiomarkersforsmokingexposureinapopulationbasedcohort
AT minkyunglim performanceofurinecotinineandhypomethylationofahrrandf2rl3asbiomarkersforsmokingexposureinapopulationbasedcohort
AT jinkyoungoh performanceofurinecotinineandhypomethylationofahrrandf2rl3asbiomarkersforsmokingexposureinapopulationbasedcohort
AT dayoungsong performanceofurinecotinineandhypomethylationofahrrandf2rl3asbiomarkersforsmokingexposureinapopulationbasedcohort
AT ehwayun performanceofurinecotinineandhypomethylationofahrrandf2rl3asbiomarkersforsmokingexposureinapopulationbasedcohort
AT eunyoungpark performanceofurinecotinineandhypomethylationofahrrandf2rl3asbiomarkersforsmokingexposureinapopulationbasedcohort